Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis

Aleksander Obtułowicz; Daryna Barouka; Dominika Kapusta; Norbert Kapczyński; Marta Lato; Andrzej Jaworek; Bartosz Obtułowicz; Anna Wojas-Pelc

doi:10.5114/pja.2025.153695

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

3/2025
vol. 12

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Opis przypadku

Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis

Aleksander Obtułowicz

¹

,

Daryna Barouka

²

,

Dominika Kapusta

²

,

Norbert Kapczyński

²

,

Marta Lato

¹

,

Andrzej Jaworek

¹

,

Bartosz Obtułowicz

²

,

Anna Wojas-Pelc

¹

Department of Dermatology, Jagiellonian University Medical College, Krakow, Poland
Students’ Dermatology Research Association, Jagiellonian University Medical College, Krakow, Poland

Alergologia Polska – Polish Journal of Allergology 2025; 12, 3: 227–231

DOI: https://doi.org/10.5114/pja.2025.153695

Data publikacji online: 2025/08/20

Pełna treść artykułu Pobierz cytowanie

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Obtułowicz A, Barouka D, Kapusta D, et al. Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis. Alergologia Polska - Polish Journal of Allergology. 2025;12(3):227-231. doi:10.5114/pja.2025.153695.

APA

Obtułowicz, A., Barouka, D., Kapusta, D., Kapczyński, N., Lato, M.,  & Jaworek, A. et al. (2025). Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis. Alergologia Polska - Polish Journal of Allergology, 12(3), 227-231. https://doi.org/10.5114/pja.2025.153695

Chicago

Obtułowicz, Aleksander, Daryna Barouka, Dominika Kapusta, Norbert Kapczyński, Marta Lato, Andrzej Jaworek,  and Bartosz Obtułowicz et al. 2025. "Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis". Alergologia Polska - Polish Journal of Allergology 12 (3): 227-231. doi:10.5114/pja.2025.153695.

Harvard

Obtułowicz, A., Barouka, D., Kapusta, D., Kapczyński, N., Lato, M., Jaworek, A., Obtułowicz, B.,  and Wojas-Pelc, A. (2025). Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis. Alergologia Polska - Polish Journal of Allergology, 12(3), pp.227-231. https://doi.org/10.5114/pja.2025.153695

MLA

Obtułowicz, Aleksander et al. "Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis." Alergologia Polska - Polish Journal of Allergology, vol. 12, no. 3, 2025, pp. 227-231. doi:10.5114/pja.2025.153695.

Vancouver

Obtułowicz A, Barouka D, Kapusta D, Kapczyński N, Lato M, Jaworek A et al. Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis. Alergologia Polska - Polish Journal of Allergology. 2025;12(3):227-231. doi:10.5114/pja.2025.153695.

Metryki PlumX:

Tumor necrosis factor-α (TNF-α) inhibitors, such as adalimumab, are widely used for the treatment of various inflammatory diseases, including psoriasis. Injection site reactions (ISRs) are common side effects, typically mild and self-limiting. Nevertheless, in some cases, ISRs may persist or evolve into more severe hypersensitivity reactions, requiring discontinuation or a change of the therapy. We present the case of a 40-year-old woman with plaque psoriasis who developed progressive ISRs and recall reactions during adalimumab therapy. Allergological diagnostics confirmed a delayed-type hypersensitivity reaction. Transitioning to an IL-12/IL-23 inhibitor resulted in clinical improvement, highlighting the importance of allergological testing and alternative biologic therapies.

Early and late allergic reactions limited to adalimumab injection sites in a patient with severe plaque psoriasis

Aleksander Obtułowicz 1 , Daryna Barouka 2 , Dominika Kapusta 2 , Norbert Kapczyński 2 , Marta Lato 1 , Andrzej Jaworek 1 , Bartosz Obtułowicz 2 , Anna Wojas-Pelc 1

Aleksander Obtułowicz

¹

,

Daryna Barouka

²

,

Dominika Kapusta

²

,

Norbert Kapczyński

²

,

Marta Lato

¹

,

Andrzej Jaworek

¹

,

Bartosz Obtułowicz

²

,

Anna Wojas-Pelc

¹